The c-ret gene encodes a receptor tyrosine kinase (RET) essential for the development of the kidney and enteric nervous system. Activation of RET requires the secreted neurotrophin GDNF (Glial cell line-Derived Neurotrophic Factor) and its high affinity receptor, a glycosyl phosphatidylinositol-linked cell surface protein GFRα1. In the developing kidney, RET, GDNF, and GFRα1 are all required for directed outgrowth and branching morphogenesis of the ureteric bud epithelium. Using MDCK renal epithelial cells as a model system, activation of RET induces cell migration, scattering, and formation of filopodia and lamellipodia. RET expressing MDCK cells are able to migrate towards a localized source of GDNF. In this report, the intracellular signaling mechanisms regulating RET dependent migration and chemotaxis are examined.
INTRODUCTION
The c-ret proto-oncogene encodes a protein (RET) of the receptor tyrosine kinase gene superfamily with a characteristic extracellular ligand binding domain, a transmembrane domain and a cytoplasmic tyrosine kinase domain. The c-ret gene is essential for normal embryonic development of the kidney and enteric nervous system and has also been associated with at least three kinds of neoplasias. In humans, RET loss-of-function results in Hirschsprung disease, a deficiency of neurons in the enteric nervous system of the gastrointestinal tract (Edery et al., 1994; Romeo et al., 1994) . Constitutively active RET causes multiple endocrine neoplasia types 2A and 2B (MEN2A, MEN2B) and familial medullary thyroid carcinoma (FMTC) (Carlson et al., 1994; Hofstra et al., 1994; Mulligan et al., 1993; Santoro et al., 1995) . Activation of the RET catalytic domain is thought to require binding of glial cell derived neurotrophic factor (GDNF) to a high affinity receptor, GFRα1 (Jing et al., 1996; Treanor et al., 1996) , which interacts with the RET extracellular domain.
Genetic analyses in mice clearly indicate that RET, GDNF, and GRFα1 are each essential for development of the mammalian kidney. Kidney development is a sequential process that begins with formation of the nephric duct, which extends from the mid-thoracic region to the cloaca of the embryo (for review, see (Davies and Bard, 1998; Lechner and Dressler, 1997) . The metanephric kidney is formed at the posterior end of the nephric duct as the ureteric bud, an outgrowth or diverticulum, extends from the duct and invades a group of surrounding cells, the metanephric mesenchyme. RET is expressed along the entire nephric duct (Pachnis et al., 1993) , whereas GDNF is expressed in the adjacent metanephric mesenchyme (Hellmich et al., 1996) . A high percentage of mice homozygous for null mutations of RET exhibit renal agenesis, because the ureteric bud does not extend at all from the nephric duct (Schuchardt et al., 1994; Schuchardt et al., 1996) . In those Ret mutants that do show some degree of ureteric bud growth, there is a block in branching morphogenesis. However, mesenchyme from the RET-knockout mice can support growth and branching of a wild-type ureter in culture and are also able to differentiate into epithelium when induced with wild-type ureteric bud. Both GDNF and GFRα1 null mutant mice exhibit complete ablation of the ureteric bud (Cacalano et al., 1998; Moore et al., 1996; Pichel et al., 1996; Sanchez et al., 1996) , whereas ectopic GDNF can stimulate ureteric bud branching morphogenesis in organ culture (Sainio et al., 1997; Vega et al., 1996) . Thus, both genetic and biochemical analyses are consistent with the hypothesis that the RET/GDNF/GFRα1 signaling 4 complex regulates the migration and/or proliferation of the renal epithelial cells that will generate the ureteric buds, its branches, and the mature collecting duct system. How the RET protein transduces the signals to mediate growth and invasion remains obscure. Because the signaling complex requires both GDNF and GFRα1, it has proved difficult to study RET activation in a ligand dependent manner. As a result, much of the early available evidence regarding downstream signaling was obtained with chimeric RET proteins or oncogenic, constitutively active forms of RET. The adaptor protein Shc binds activated RET upon phosphorylation of tyrosine 1062 (Arighi et al., 1997) and is necessary for mitogenic activity (Durick et al., 1998; Durick et al., 1995) . The enigma protein, which contains a PDZ domain and 3 LIM domains, also binds to tyrosine 1062 but only if it is phosphorylated (Durick et al., 1998; Durick et al., 1996) . The ability of oncogenic RET to transform cells also requires a docking site for phospholipase Cγ at tyrosine 1015 (Borrello et al., 1996) . More recently, ligand dependent activation of RET in neuroblastoma cells, which express GFRα1, results in increased PI3K activity and the phosphorylation of proteins located at the focal adhesion complex, including focal adhesion kinase (FAK), paxillin, and p130
Cas (Murakami et al., 1999) . The MEN2A form of oncogenic RET can activate PI3K, apparently also through tyrosine 1062, resulting in activation of Akt/PKB and phosphorylation of forkhead transcription factors (Segouffin-Cariou and Billaud, 2000) . Although tyrosine 1062 appears essential for transformation and mitogenesis, it is unclear whether wild-type RET mediates cell proliferation in vivo, particularly in the developing urogenital system. At least seven other tyrosine residues can be phosphorylated in the activated form of RET (Liu et al., 1996) , the significance of which remain unclear.
The migration and invasion of ureteric bud epithelium into the adjacent metanephric mesenchyme is an example of chemotaxis at the tissue level. Using MDCK renal epithelial cells expressing RET, we have previously shown that GDNF promotes cell scattering, the extension of lamellipodia and filopodia, and increased cell motility (Tang et al., 1998) . RET expressing epithelial cells are able to migrate towards a localized source of GDNF. Thus, GDNF may be a 5 target derived guidance cue for the ureteric bud epithelium. Cell motility is dependent, in part, on reorganization of the cytoskeleton, which can be mediated by PI3K (Fruman et al., 1998; Wennstrom et al., 1994) . In this report, the RET expressing MDCK cells are used to address the role of phosphotidylinositol-3 kinase in epithelial cell migration and ureteric bud outgrowth.
Ligand activation of RET in MDCK cells results in increased PI3 kinase activity and increased phosphorylation of Akt/PKB, whereas inhibition of PI3 kinase blocked GDNF dependent cell migration. Furthermore, we demonstrate that PI3 kinase is essential for mediating GDNF dependent ureteric bud outgrowth and branching morphogenesis in kidney organ cultures.
Inhibitors of the ERK1/2 and p38 MAP kinase pathways did not grossly affect initial ureteric bud outgrowth, suggesting that these pathways are not essential for transducing RET signaling in the developing ureteric bud epithelia. However, p38 inhibitors did affect branching morphogenesis at later stages and may indicate a role for this MAPK in regulating the site or number of branch points. Our results point to an essential role for PI3K in epithelial cell scattering, invasion, and branching morphogenesis in the developing kidney.
MATERIALS AND METHODS

Cell Lines and Organ Culture
RET-transfected MDCK cells were maintained in Dulbeco's modified Eagles medium (Glucose concentration: 450mg/dL) supplemented with 10% fetal bovine serum and 100U/ml penicillin and 100µg/ml streptomycin under humidified 5% CO2/95% air at 37oC. Single cell suspension was obtained by incubating the monolayer culture in 0.05% trypsin solution. For determination of cell number, suspended cells were counted with a hemocytometer in the presence of trypan blue.
Timed matings were set up with the day of the vaginal plug designated as E0.5. Organ
Culture was done in 6 well plates using 0.4 micron Transwell inserts and DMEM supplemented with 10% fetal calf serum. For the bead experiments, heparin acrylamide beads (Sigma, St. Louis) 6 were incubated in 10 ng/µl of recombinant GDNF (Promega Corp., Madison. WI) or BSA for 1 h on ice and washed briefly in PBS before placing on organ cultures. Whole mount antibody staining of organ cultures was done as described (Cho et al., 1998) . Briefly, tissues were fixed in methanol for 10 min. and washed 2 times for 10 min. in PBS, 0.1% Tween-20 (PBST). AntiPax2 (0.5 mg/ml) and anti-Pan-cytokeratin (Sigma, 1:50) antibodies were diluted in PBST, 2%
goat serum and incubated for 3-4h at 4 o C. Tissues were washed in PBST 4 times for 1h each with one wash overnight at 4 o C. The second antibodies, FITC-anti-mouse (Sigma) and TRITC-antirabbit (Sigma), were used at 1:100 dilution in PBST, 2% goat serum and incubated for 3 h. After extensive washing the samples were placed on slides and covered with gelvatol.
PI3K activity assay
Subconfluent cells were cultured in DMEM containing 10% serum with or without 100 ng/ml of soluble, recombinant human GFRα1 ( 
Immunoblotting
Cells were lysed in IP-lysis buffer at and cleared by centrifugtion and protein levels quantified by the Bio-Rad colorometric assay. 6X SDS/PAGE sample buffer was added and samples boiled for 5 min. Samples were run on a 7.5% polyacrylamide gel, transferred to PVD membrane and blocked with 5% milk in Tris buffered saline. Membranes were immunoblotted with anti-p-Akt antibody, anti-Akt, and anti-pERK1/2 (Cell Signaling Technologies, Beverly, MA) in 10 mM Tris pH 7.5, 100 mM NaCl, 0.1% Tween-20, 1% nonfat milk. Secondary antibodies conjugated to horseradish peroxidase were used at a 1:10,000 dilution and the signal visualized by Enhanced Chemiluminescense (Amersham, Piscataway, NJ) using recommended protocols.
Cell migration and chemotaxis assay
For migration assays, cells from monolayer cultures were treated with 0.2% trypsin/EDTA, washed once with 10% serum media and resuspended in 10% serum media. The migration assay was performed using a 48-well modified Boyden chamber (NeuroProbe Inc., Rockville, MD) with the lower chambers filled with 10% serum media containing GDNF (50 ng/ml) and GFRα1 (100 ng/ml). Collagen-coated polycarbonate filters with 8 µm pore size were used as the membranes separating upper and lower chambers. Each well was plated with 50 µl suspended cells (5 x 10 5 /ml) and the Boyden chamber was incubated at 37 o C in 5% CO 2 . After 20 hours, cells on the 8 upper surface of the membrane were removed using a cotton swab. The membrane was then fixed with methanol for 8 minutes and stained with Giemsa. The cells on the lower surface were counted under light microscope at high power magnification (X 400). Multiple fields (four to eight) were counted.
RESULTS
Previously, we characterized stably transformed MDCK cell lines expressing wild-type RET or kinase deficient mutants (Tang et al., 1998) . The Ret9 cell line expresses full length 1115 amino acid form of the human RET protein, whereas the Km line expresses a point mutant of RET that alters the ATP binding site within the kinase domain. In response to GDNF and soluble GFRα1, activated RET promotes cell scattering and chemotaxis of Ret9 cells to a localized source of GDNF. Cell scattering, migration, and chemotaxis are mediated in part by the reorganization of the cytoskeleton. PI3K is known to regulate the rearrangement of the cytoskeleton (Khwaja et al., 1998) and is activated upon HGF-induced cell motility (Derman et al., 1995) . To determine whether PI3K functions in GDNF/RET-induced cell motility and chemotaxis, in vitro PI3K assays were done with Ret9 and Km cells (Fig. 1 ). Increase in PI3K activity was already apparent one hour after GDNF treatment, with a peak activity at 12 hours post GDNF addition (Fig. 1A) . In long term stimulation assays (Fig. 1B) , only Ret9 cells showed an increase in steady-state PI3K activity of 4-5 fold, whereas Km cells had no response to GDNF.
Since activation of PI3K leads to phosphorylation of Akt/PKB, we examined levels of phospho-Akt with specific antibodies (Fig. 2) . In Ret9 cells, an increase in levels of phospho-Akt could be discerned in as little as 15 minutes after GDNF/GFRα1 treatment. Over time, levels of phospho-Akt increased significantly, whereas the total levels of Akt were unaffected. To examine activation of the MAP kinaase pathway, levels of phospho-ERK1/2 were examined. While there was a slight increase in phospho-ERK1/2 after 15 minutes and a peak at 30 minutes, phospho-9 ERK levels were not sustained. Thus, activation of RET in response to ligands results in a 4 fold increase in PI3K activity and an approximately 8-10 fold increase in activated Akt.
To confirm that PI3K was essential for GDNF/RET induced cell motility and chemotaxis of Ret9 cells, the specific PI3K inhibitor LY294002 was used in the transfilter migration assay (Fig.   3 ). Cells were seeded as a monolayer on top of a Transwell insert and GDNF/GFRα1 was added to the bottom, or basal side, of the dish. In a dose response experiment (data not shown), the migration capacity of Ret9 cells was reduced to base line levels by LY294002 at a concentration of 10 µM. At this concentration, Ret9 cells all showed a significant reduction in RET mediated transfilter migration ability (Fig. 3) . The effect of PI3K inhibition on cell proliferation was negligible as the numbers of cells migrating through the filter in the absence of GDNF was similar to that of control media. The specific MAPK inhibitor PD98059 had little effect on the mobility of Ret9 cells in response to GDNF/GFRα1 (data not shown). Thus, the PI3K appears to be the predominant signaling pathway required for migration and chemotaxis, in response to ligand activation of RET in renal epithelial cells.
Given the requirement for PI3 kinase in our model system of epithelial cell chemotaxis, we next examined if PI3 kinase was necessary for the outgrowth of the ureteric bud. Ectopic ureteric bud outgrowth can be observed in an organ culture system in response to GDNF (Brophy et al., 2001; Sainio et al., 1997) . The region of intermediate mesoderm, containing both nephric ducts, the mesonephric tubules, and the posterior peri-ductal mesenchyme was dissected from E10.5 mouse embryos and laid flat on a Transwell filter. Heparin acrylamide beads were soaked in GDNF and placed along the midline, between the bilateral nephric ducts of the cultures. Normally, the ureteric buds grow laterally into the metanephric mesenchyme, at the posterior end of the intermediate mesoderm. However, GDNF beads can promote budding of the nephric duct epithelial towards the midline at more anterior positions (Fig. 4) . Using the formation of ectopic ureteric buds as a biological readout for RET activation and signaling, the effects of various inhibitors were examined. Neither the MEK1 inhibitor PD98059 (10 µM) nor the p38 MAP kinase inhibitor SB203580 (20 µM) significantly reduced the ability of GDNF to promote budding, as in the controls 4/4 cultures showed ectopic ureteric buds. However, the formation of ectopic ureteric buds from the nephric duct epithelial was completely inhibited by the LY294002 (20 µM) in all cultures examined. Indeed the PI3 kinase inhibitor also blocked formation of the endogenous ureteric buds at the posterior aspect. Cells adjacent to the posterior nephric ducts still expressed the Pax2 gene, as did the nephric duct epithelial cells, indicating no gross effects on cell viability.
To examine the effect of PI3 kinase inhibition on branching morphogenesis, we cultured E11.5 metanephric kidneys on Transwell filters with the same inhibitors as above (Fig. 5) .
Strikingly, we observed a complete inhibition of branching in the presence of 20 µM LY294002, whereas 10 µM PD98059 had no significant effect on either branching of the ureteric bud epithelia, condensation of the mesenchyme, or epithelial conversion. Inhibition of the p38 MAP kinase did have some effects on the branching pattern of the ureteric bud epithelia. In the presence of 20 µM SB203580, ureteric bud branches were elongated and appeared less dichotomous; mesenchyme aggregation and epithelial conversion were unaffected. The effects of the specific inhibitors were examined by western blotting of protein lysates from E11.5 kidney rudiments cultured for 48 h (Fig. 6 ). Incubation with 10 µM PD98059 resulted in a near complete inhibition of ERK1/2 phosphorylation as determined by western blotting with anti-Phospho-ERK antibodies, yet there was little effect on the expression of phospho-AKT. In the presence of 20 µM LY294002 however, expresion of phospho-ERK was unaffected and the levels of phospho-AKT were reduced approximately 3-4 fold as determined by densitometer scanning. To test the efficacy of the p38 MAPK inhibitor, we tried immunoblotting for phospho-ATF2, a target of the p38 kinase.
However, we were unable to detect this protein in control or treated organ cultures. The complete block of branching morphogenesis observed upon inhibition of PI3 kinase was not due to cell death, as the mesenchymal aggregates continued to express Pax2, showed activation of E-cadherin and cadherin-6 expression, and expression of phosho-ERK. The initial mesenchymal aggregates began the process of epithelial conversion, however no new aggregates were induced due to the lack of branching morphogenesis and subsequent induction.
DISCUSSION
The embryonic kidney arises from two main cell types, the ureteric bud epithelium and the metanephric mesenchyme. Outgrowth of the ureteric bud epithelium and invasion into the metanephric mesenchyme depends on GDNF activation the RET receptor tyrosine kinase. In this report, we demonstrate that GDNF dependent ureteric bud outgrowth is mediated by PI3 kinase pathway. These conclusions are based on the following observations. Using our MDCK model system, recombinant GDNF and GFRα1 can activate RET resulting in increased levels of PI3 kinase activity. This is accompanied by rapid elevation of phospho-Akt, a downstream target of PI3 kinase. GDNF dependent migration and chemotaxis of Ret9 cells is completely blocked by the PI3 kinase inhibitor LY294002. Using an embryonic organ culture system, GDNF can induce ectopic ureteric bud outgrowth from the nephric duct epithelia, also in a PI3 kinase dependent manner. Furthermore, inhibitors of the ERK1/2 or p38 MAP kinases at concentrations used in this study had little effect on the initial GDNF mediated ureteric bud outgrowth in our organ culture system. Branching morphogenesis of the ureteric bud epithelia was effected by p38 inhibition at later developmental stages and suggests a role for this MAPK in branch point patterning. These results suggest that increased levels of PI3 kinase in response of RET activation is a necessary signaling mechanism mediating chemotaxis of the renal epithelial cells.
The signaling mechanisms of RET mediated cell survival, chemotaxis, and oncogenesis have been studied in a variety of systems. We believe that activation of PI3 kinase is a direct response to RET activation, because: 1) inhibition of PI3 kinase in both MDCK cells and in organ culture blocks RET dependent chemotaxis, 2) PI3 kinase activity and AKT phosphorylation are relatively rapid responses to RET activation.
3) The activation of PI3 kinase and a direct interaction with RET have been reported in other cell types. Activation of PI3 kinase has been observed in GDNF dependent neuronal survival (Besset et al., 2000; Encinas et al., 2001 ) and in HGF mediated MDCK cell scattering (Khwaja et al., 1998) . PI3 kinase activity has also been linked to the transforming ability of the c-ret oncogene, through a docking site at tyrosine 1062 (Segouffin-Cariou and Billaud, 2000). Besset et al. (Besset et al., 2000) describe increased PI3K activity in RET/GFRα1 transfected NIH3T3 cells upon GDNF stimulation that was mediated by two potential docking sites, tyrosines 1062 and 1096, at least one of which interacts with the insulin receptor substrate IRS1 (Melillo et al., 2001a) . The 1062 tyrosine residue has also been implicated in activation of MAP kinase pathways, through binding of FRS2 (Melillo et al., 2001b) , in oncogenic forms of RET. Thus, it is not surprising that PI3 kinase is also required for mediating the GDNF/RET signal in the ureteric bud epithelium. However, these results do not preclude the possibility that PI3 kinase is indirectly by RET. Nevertheless, its activity is essential for controlling the biological response to the RET/GDNF/GFRα1 signaling pathway.
Our experiments with the Ret9 MDCK cell derivatives utilize a soluble form of the Gpilinked GFRα1 high affinity receptor. This soluble form increases GDNF/GFRα1 mediated signaling in neuronal cell lines and alters the kinetics of lipid raft formation to produce a more prolonged response (Paratcha et al., 2001) . Similarly, the MDCK cell migration assay may also exhibit a more robust response in our experiments, as the soluble GFRα1 signals in trans. Thus, we have utilized an organ culture assay, where GFRα1 is expressed in cis by the ureteric bud epithelium, to confirm the role of PI3 kinase in ureteric bud outgrowth. Normally, GFRα1 is expressed by both metanephric mesenchyme and ureteric bud epithelia (Sainio et al., 1997) . Our bead experiments would suggest that expression of GFRα1 by the epithelia is sufficient to mediate a GDNF dependent response, although expression and release of GFRα1 by the mesenchyme may potentiate this response in vivo. In neuronal cells, GDNF/GFRα1 stimulates both cell spreading 13 and neurite outgrowth, which can be blocked by the PI3 kinase and MEK1 inhibitors (Paratcha et al., 2001) . Thus, PI3 kinase appears to be a common target of activated RET in both neurons and the ureteric bud epithelia.
While we were not surprised to see a dramatic effect of PI3 kinase inhibitor on branching morphogenesis, the role of ERK1/2 was less clear. Phosphorylation of ERK1/2 by the upstream kinase MEK1 has been linked to RET activation in a variety of cell types and is thought to be important for oncogenic RET activity. We also see a transient increase in ERK phosphorylation in the Ret9 cells, although basal levels are already quite high. Thus, it was surprising to see that 10
µM PD98059 had little effect on the outgrowth of ectopic ureteric buds in response to the GDNF beads, nor did it inhibit branching morphogenesis in whole kidney cultures. This is in direct contrast to a recent report showing a reduction in branching morphogensis with 10 µM and complete inhibition by 25 µM PD98059 (Fisher et al., 2001) . Given the normal morphology observed in our assay, it was important to show a lack of ERK1/2 phosphorylation. Even at 10 µM PD98059 levels of phospho-ERK1/2 were undetectable whereas levels of phospho-Akt are unaffected. At present, it is difficult to reconcile these differences, though subtle differences in culture conditions may play a role. Given the transient increase in ERK phosphorylation observed in the MDCK cells, it is also possible that the time of explant may account for some of the reported differences.
Within the context of the developing urogenital system, ectopic GDNF is sufficient to induce ureteric bud outgrowth from the posterior nephric duct epithelia (Brophy et al., 2001; Sainio et al., 1997) . The expression of GDNF in the metanephric mesenchyme is activated by the Pax2 protein, whereas GDNF activity is suppressed by BMP4 (Brophy et al., 2001; Miyazaki et al., 2000) though it is not clear whether this is due to suppression of RET signaling. In vitro,
MDCK renal epithelial cells that express RET are able to migrate towards a source of GDNF (Tang et al., 1998) . In order for epithelial cells to migrate in vivo, a delicate balance between cell motility and maintenance of cellular junctions must be preserved. Thus, signaling through the RET protein must allow for cell movement without destroying the essential nature of the epithelial sheet. The migration of cells requires the reorganization of the actin cytoskeleton, the formation of cellular processes, such as lamellipodia and filopodia, and the association of focal adhesion complexes (Cooper, 1991) , as is observed upon RET activation in Ret9 cells (Tang et al., 1998) . The extension of cellular processes may be essential for chemotaxis as local concentrations of ligands are sensed to induce directional migration. Moreover, PI3K has been implicated in the regulation of the actin cytoskeleton by growth factors such as PDGF and insulin (Kotani et al., 1994; Nobes et al., 1995; Wennstrom et al., 1994) and in MDCK cells upon HGF-induced cell scattering (Khwaja et al., 1998; Ridley et al., 1995) . How PI3 kinase transduces the GDNF/RET mediated chemotactic response of renal epithelial cells remains to be clarified. However, it appears likely that reorganization of the cytoskeleton and formation of cellular processes through activation of downstream effectors of PI3 kinase, such as Akt, FAK, and paxillin, will be essential.
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